USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
TETRA DISCOVERY PARTNERS, LLC
Address:
910 ROSEWOOD AVE SE
GRAND RAPIDS, MI 49506-3362
EIN:
127399859
DUNS:
967529939
Number of Employees:
6
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $698,827.00 1
SBIR Phase II $3,003,708.00 1

Award List:

Phosphodiesterase Type IV (PDE4) Isoform Selective Allosteric Modulators For Psyc

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$698,827.00
Agency:
HHS
Principal Investigator:
Mark E. Gurney – 616-635-0937
Abstract:
DESCRIPTION (provided by applicant): The broad goal of the SBIR proposal is to understand the pharmacology of phosphodiesterase 4 (PDE4) allosteric modulation in the CNS as it relates to psychiatric disorders. We recently described the discovery of isoform-selective, allosteric modulators of PDE4D… More

PDE4B Inhibitors For Treating Major Depression

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$3,003,708.00
Agency:
HHS
Principal Investigator:
Mark E. Gurney – 616-635-0937
Abstract:
DESCRIPTION (provided by applicant): Tetra Discovery Partners proposes to develop a new treatment for major depressive disorder based on inhibition of phosphodiesterase 4B (PDE4B). Uniquely, the Tetra drug will address inflammation as a contributor to depression. This is a new mechanism of action… More